Nektar Therapeutics' President and CEO, Howard Robin, to Present at the 40th Annual J.P. Morgan Virtual Healthcare Conference

Rhea-AI Summary

Nektar Therapeutics (Nasdaq: NKTR) CEO Howard Robin will present at the 40th Annual J.P. Morgan Virtual Healthcare Conference on January 11, 2022, at 3:00 p.m. ET. The event will be accessible via a webcast linked on Nektar's Investor Events Calendar and will remain available for replay until February 11, 2022. Nektar is a biopharmaceutical company based in San Francisco, focusing on R&D in oncology, immunology, and virology.

News Market Reaction – NKTR

-6.92%

-6.92% Session move

In the trading session that priced this news, NKTR declined 6.92%, reflecting a notable negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN FRANCISCO, Jan. 5, 2022 /PRNewswire/ -- Nektar Therapeutics' (Nasdaq: NKTR) President and Chief Executive Officer, Howard Robin, is scheduled to present at the upcoming 40th Annual J.P. Morgan Virtual Healthcare Conference on Tuesday, January 11, 2022 at 3:00 p.m. Eastern Time. The presentation and Q&A session will be accessible via a Webcast through a link posted on the Investor Events Calendar section of the Nektar website: https://ir.nektar.com/events-and-presentations/events. This webcast will be available for replay until February 11, 2022.

About Nektar

Nektar Therapeutics is a biopharmaceutical company with a robust, wholly owned R&D pipeline of investigational medicines in oncology, immunology and virology well as a portfolio of approved partnered medicines. Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India. Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com.

Contact:

For Investors:
Vivian Wu of Nektar Therapeutics
628-895-0661

For Media:
Dan Budwick of 1AB
dan@1abmedia.com
973-271-6085

View original content to download multimedia:https://www.prnewswire.com/news-releases/nektar-therapeutics-president-and-ceo-howard-robin-to-present-at-the-40th-annual-jp-morgan-virtual-healthcare-conference-301454205.html

SOURCE Nektar Therapeutics

FAQ

When is the Nektar Therapeutics presentation at the J.P. Morgan Healthcare Conference?

The Nektar Therapeutics presentation is scheduled for January 11, 2022, at 3:00 p.m. ET.

How can I access the Nektar Therapeutics presentation?

The presentation can be accessed via a webcast linked on the Nektar Investor Events Calendar.

Until when will the Nektar Therapeutics webcast be available for replay?

The Nektar Therapeutics webcast will be available for replay until February 11, 2022.

Who is presenting for Nektar Therapeutics at the conference?

Howard Robin, President and CEO of Nektar Therapeutics, will be presenting.

What topics will be covered in the Nektar Therapeutics presentation?

The presentation will likely cover Nektar's R&D pipeline and investigational medicines across oncology, immunology, and virology.